Barlow Twins Deep Neural Network for Advanced 1D Drug-Target Interaction Prediction
원문 초록
Accurate prediction of drug-target interactions is critical for advancing drug discovery. By reducing time and cost, machine learning and deep learning can accelerate this laborious discovery process. In a novel approach, BarlowDTI, we utilise the powerful Barlow Twins architecture for feature-extraction while considering the structure of the target protein. Our method achieves state-of-the-art predictive performance against multiple established benchmarks using only one-dimensional input. The use of gradient boosting machine as the underlying predictor ensures fast and efficient predictions without the need for substantial computational resources. We also investigate how the model reaches its decision based on individual training samples. By comparing co-crystal structures, we find that BarlowDTI effectively exploits catalytically active and stabilising residues, highlighting the model's ability to generalise from one-dimensional input data. In addition, we further benchmark new baselines against existing methods. Together, these innovations improve the efficiency and effectiveness of drug-target interaction predictions, providing robust tools for accelerating drug development and deepening the understanding of molecular interactions. Therefore, we provide an easy-to-use web interface that can be freely accessed at https://www.bio.nat.tum.de/oc2/barlowdti .
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
B-XAIC Dataset: Benchmarking Explainable AI for Graph Neural Networks Using Chemical Data
Assay2Mol: large language model-based drug design using BioAssay context
PocketVina Enables Scalable and Highly Accurate Physically Valid Docking through Multi-Pocket Conditioning
Fast Bayesian Optimization of Function Networks with Partial Evaluations
Robust Molecular Property Prediction via Densifying Scarce Labeled Data
MTPNet: Multi-Grained Target Perception for Unified Activity Cliff Prediction
토론
이 논문과 연결된 포럼 글이 아직 없습니다.